Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

New Alzheimer's drug clears FDA advisory vote despite unknowns.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Science (New York, N.Y.) [Science] 2024 Jun 14; Vol. 384 (6701), pp. 1164-1165. Date of Electronic Publication: 2024 Jun 13.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

'Damning' FDA inspection report undermines Alzheimer's drug.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Scientific Misconduct* ; Spiro Compounds*/Spiro Compounds*/Spiro Compounds*/therapeutic use

  • Source: Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1165-1166. Date of Electronic Publication: 2024 Mar 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Probe of Alzheimer's studies finds 'egregious misconduct'.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/prevention & control ; Spiro Compounds* ; Scientific Misconduct*

  • Source: Science (New York, N.Y.) [Science] 2023 Oct 20; Vol. 382 (6668), pp. 251-252. Date of Electronic Publication: 2023 Oct 19.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Alzheimer's drug approval gets a mixed reception.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Drug Approval*

  • Source: Science (New York, N.Y.) [Science] 2023 Jan 13; Vol. 379 (6628), pp. 126-127. Date of Electronic Publication: 2023 Jan 12.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Doubts persist for claimed Alzheimer's drug.

Subjects: Drug Approval*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*therapy ; Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*antagonists & inhibitors

  • Source: Science (New York, N.Y.) [Science] 2019 Dec 13; Vol. 366 (6471), pp. 1298.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

U.S. science budget. Advocates win 'exceptional' boost for Alzheimer's research.

Subjects: Alzheimer Disease* ; Research Support as Topic*; Biomedical Research/Biomedical Research/Biomedical Research/*economics

  • Source: Science (New York, N.Y.) [Science] 2012 Feb 24; Vol. 335 (6071), pp. 902.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Intellectual property. Alzheimer's researcher in Japan accused of economic espionage.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/economics ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/genetics ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology

  • Source: Science (New York, N.Y.) [Science] 2001 May 18; Vol. 292 (5520), pp. 1274-5.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Major setback for Alzheimer's models.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Disease Models, Animal*

  • Source: Science (New York, N.Y.) [Science] 1992 Mar 06; Vol. 255 (5049), pp. 1200-2.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Alzheimer's congress. Drug shows promise for advanced disease.

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Excitatory Amino Acid Antagonists/Excitatory Amino Acid Antagonists/Excitatory Amino Acid Antagonists/*therapeutic use ; Memantine/Memantine/Memantine/*therapeutic use

  • Source: Science (New York, N.Y.) [Science] 2000 Jul 21; Vol. 289 (5478), pp. 375-7.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

OTA cites financial disaster of Alzheimer's.

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*economics; Government Agencies ; Humans

  • Source: Science (New York, N.Y.) [Science] 1987 Apr 17; Vol. 236 (4799), pp. 253.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
  • 1-10 of  17 results for ""Alzheimer Disease""